Immucell (ICCC) Gross Margin (2009 - 2026)
Immucell's Gross Margin came in at 44.22% for Q3 2026, up 1.30 percentage points from 42.92% a year earlier and up 10.30 percentage points from the prior quarter.
Immucell (ICCC) Gross Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Immucell reported Gross Margin of 40.83%, down 0.10 percentage points year-over-year; for FY2025, it came in at 41.40%, up 11.43 percentage points from FY2024.
- Gross Margin carries a five-year change of -3.33 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 29.97% in FY2024 (+7.83 pp), 22.15% in FY2023 (-19.05 pp), 41.19% in FY2022 (-3.79 pp) and 44.98% in FY2021 (+0.25 pp).
- The five-year range for quarterly Gross Margin is 8.73% (Q1 2023) to 51.72% (Q1 2022).
- Year-over-year, Gross Margin increased in six of the last seven quarters, with an average year-over-year change of +6.33 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q1 2024 (a gain of 22.90 percentage points), and the weakest in Q1 2023 (a drop of 43.00 percentage points).
- Business Quant data shows ICCC's Gross Margin at 33.92% (Q2 2026), 44.97% (Q1 2026) and 38.16% (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 75.71% |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 44.22% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 44.22% |
| Jun 30, 2026 | 33.92% |
| Mar 31, 2026 | 44.97% |
| Dec 31, 2025 | 38.16% |
| Sep 30, 2025 | 42.92% |
| Jun 30, 2025 | 43.72% |
| Mar 31, 2025 | 41.58% |
| Dec 31, 2024 | 36.53% |
| Sep 30, 2024 | 26.34% |
| Jun 30, 2024 | 22.48% |
| Mar 31, 2024 | 31.63% |
| Sep 30, 2023 | 23.48% |
| Jun 30, 2023 | 29.55% |
| Mar 31, 2023 | 8.73% |
| Dec 31, 2022 | 25.37% |
| Sep 30, 2022 | 38.49% |
| Jun 30, 2022 | 44.22% |
| Mar 31, 2022 | 51.72% |
| Dec 31, 2021 | 47.04% |
| Sep 30, 2021 | 46.96% |
Immucell Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();